Kyntra Bio, Inc. (KYNB)
6.99
+0.05
(+0.72%)
USD |
NASDAQ |
May 22, 16:00
6.98
-0.01
(-0.14%)
After-Hours: 20:00
Kyntra Bio Market Cap : 28.25M for May 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anixa Biosciences, Inc. | 93.54M |
| GT Biopharma, Inc. | 15.87M |
| Perspective Therapeutics, Inc. | 453.90M |
| XOMA Royalty Corp. | 522.33M |
| Gossamer Bio, Inc. | 49.31M |
Market Cap Related Metrics
| PE Ratio | 0.2545 |
| PS Ratio | 3.801 |
| Price | 6.99 |
| Earnings Yield | 392.9% |
| Normalized PE Ratio | 0.2437 |